Comment on Alzheimer’s drug lecanemab
Alzheimer's Society and Professor Sir John Hardy respond to results for Alzheimer's drug lecanemab: A paper published today in The New England Journal of Medicine...
The Neurodiversity category celebrates and explores the varied ways human brains can function, encompassing conditions such as autism, ADHD and other cognitive profiles. It highlights lived experience, research, support strategies and societal perspectives, while advocating for understanding, inclusion and respect. With thoughtful, informed content, this category aims to broaden appreciation of neurological differences and promote wellbeing across diverse communities.